SCHEMBL4779787

SCHEMBL4779787

Cc1ccc(F)c(N2CC3C(C2)C3N(Cc2ccccc2)Cc2ccccc2)c1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 1/20 0.38
UBE2M P61081 2/20 0.37
DCUN1D1 Q96GG9 2/20 0.37
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
KIF11 P52732 2/20 0.34
KCNH2 Q12809 1/20 0.34
CYP2C19 P33261 1/20 0.34
RAB9A P51151 2/20 0.34
DPP4 P27487 1/20 0.34
DPP8 Q6V1X1 1/20 0.34
DPP9 Q86TI2 1/20 0.34
DPP7 Q9UHL4 1/20 0.34
LMNA P02545 1/20 0.33
POLB P06746 1/20 0.33
HTR1A P08908 1/20 0.33
ADRA1B P35368 1/20 0.33
ACHE P22303 1/20 0.33
BACE1 P56817 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4781178 0.90 UBE2M (0.39) UBE2MDCUN1D1MEN1KMT2ACYP2C19
SCHEMBL4776184 0.85 DRD2 (0.42) MEN1KMT2ACYP2C19LMNAPOLB
SCHEMBL4780326 0.84 CHRM4 (0.40) UBE2MDCUN1D1DPP4DPP8DPP9
SCHEMBL4778369 0.84 NOTUM (0.40) MEN1KMT2ALMNAPOLB
SCHEMBL4776176 0.83 FFAR4 (0.40) FFAR4UBE2MDCUN1D1MEN1KMT2A
SCHEMBL4774338 0.81 DRD2 (0.32) DPP4DPP8DPP9DPP7
SCHEMBL4779536 0.81 DRD2 (0.32) DPP4DPP8DPP9DPP7
SCHEMBL4321609 0.80 GRM5 (0.42) MEN1KMT2ADPP4DPP8DPP9
SCHEMBL4775240 0.78 MEN1 (0.41) UBE2MDCUN1D1MEN1KMT2ADPP4
SCHEMBL4780332 0.78 CHRM4 (0.38) UBE2MDCUN1D1MEN1KMT2ACYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008010061-A2 3-AZABICYCLO [3.1.0] HEXANE VANILLOID RECEPTOR LIGANDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND PROCESSES FOR THEIR PREPARATION GLENMARK PHARMACEUTICALS S.A. (US) 2008-01-24 WO disclosed